Jurgen Holzapfel

Title: Jurgen Holzapfel: Innovator in Gamma Globulin Preparation

Introduction

Jurgen Holzapfel is a notable inventor based in Eschwege, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of gamma globulin for intravenous administration. His innovative approach has the potential to enhance the efficacy and safety of gamma globulin treatments.

Latest Patents

Jurgen Holzapfel holds a patent for a process titled "Process for preparing gamma globulin suitable for intravenous." This improved method involves dissolving gamma globulin precipitated from blood or blood products in a solution, followed by a series of steps that include separating non-dissolved precipitate, adding polyethylene glycol, and adjusting concentrations to achieve purified gamma globulin. The process is characterized by its use of a neutral pH solution and specific concentrations of polyethylene glycol, ensuring a high-quality product for medical use. He has 1 patent to his name.

Career Highlights

Holzapfel is associated with Armour Pharma GmbH, where he applies his expertise in pharmaceutical innovations. His work focuses on improving processes that enhance the quality of medical treatments, particularly in the area of immunoglobulin therapies.

Collaborations

Throughout his career, Jurgen Holzapfel has collaborated with esteemed colleagues, including Jurgen-Dietrich Friedrich-Fiechtl and Bernhard Kerner. These partnerships have contributed to the advancement of research and development in the pharmaceutical industry.

Conclusion

Jurgen Holzapfel's contributions to the preparation of gamma globulin represent a significant advancement in medical science. His innovative processes and collaborations continue to impact the field positively.